Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.7M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
26.7M
-
Shares change
-
+26.7M
-
Total reported value, excl. options
-
$9.63M
-
Value change
-
+$9.63M
-
Number of buys
-
2
-
Price
-
$0.36
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q1 2023
2 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q1 2023.
GeneDx Holdings Corp. - Common Stock (WGS) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.7M shares
of 28.7M outstanding shares and own 92.98% of the company stock.
Largest 2 shareholders include MARSHALL WACE, LLP (25.1M shares) and PRICE T ROWE ASSOCIATES INC /MD/ (1.6M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.